A Study of Risperidone Monotherapy in Bipolar Anxiety
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David V. Sheehan, MD, MBA
University of South Florida College of Medicine
Principal Investigator - Paul E. Keck, MD
University of Cincinatti, Department of Psychiatry
Principal Investigator - Susan L. McElroy, MD
University of Cincinatti, Department of Psychiatry
Principal InvestigatorKOL profile → - Trisha - Suppes, MD, PhD
University of Texas Southwestern Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Florida Psychiatry Center
Tampa, Florida, United States
- University of Cincinatti
Cincinnati, Ohio, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2003
- Primary completion
- —
- Completion
- 30 Sept 2006
- Last update posted
- 11 Sept 2006
- Registered enrollment
- 60
- Registry id
- NCT00167479
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.